Table 2 Predictors of survival of hospitalized children with COVID-19, Mexico 2020–2021
From: Decreased survival in children inpatients with COVID-19 and antibiotic prescription
Characteristic | HR (95% CI),\(p\) | |||||
|---|---|---|---|---|---|---|
Bivariate analysis | Multiple analysis | |||||
Sex | ||||||
Girl | 1.00 | 1.00 | ||||
Boy | 0.84 (0.61–1.16) | 0.301 | 0.82 (0.59–1.13) | 0.227 | ||
Age group (years) | ||||||
< 1 | 1.00 | 1.00 | ||||
1–4 | 0.96 (0.67–1.39) | 0.836 | 0.97 (0.67–1.41) | 0.883 | ||
5–9 | 1.11 (0.74–1.67) | 0.617 | 1.13 (0.75–1.71) | 0.556 | ||
Date of symptoms onset | ||||||
March 2020–April 2021 | 1.00 | 1.00 | ||||
May 2021–December 2021 | 0.86 (0.60–1.23) | 0.401 | 0.88 (0.61–1.27) | 0.504 | ||
Days from symptoms onset to healthcare-seeking | 1.06 (1.01–1.11) | 0.015 | 1.05 (1.01–1.10) | 0.040 | ||
Antibiotic (any) was prescribed at hospital admission | ||||||
No | 1.00 | 1.00 | ||||
Yes | 1.82 (1.25–2.66) | 0.002 | 1.50 (1.01–2.22) | 0.043 | ||
Pneumonia diagnosis at hospital admission | ||||||
No | 1.00 | 1.00 | ||||
Yes | 2.15 (1.53–3.03) | < 0.001 | 1.94 (1.37–2.77) | < 0.001 | ||
Cardiovascular disease | ||||||
No | ||||||
Yes | 2.04 (0.94–4.44) | 0.073 | 1.90 (0.87–4.14) | 0.106 | ||